Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PlexBio has developed and commercialized multiplex molecular diagnostic platforms capable of high-throughput analysis for oncology and infectious disease applications. Their πCode® technology enables simultaneous detection of numerous genetic markers from a single sample. The company’s products have received international certifications including CE-IVDR, TFDA GMP/QMS, and ISO13485. They have also launched PCR-based coronavirus detection kits with CE mark approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PlexBio.